The purpose of this study is to evaluate 3D dose reconstruction of pretreatment verification plans using multiple 2D planes acquired from the OCTAVIUS phantom and the Seven29 detector array. Eight VMAT patient treatment plans of different sites were delivered onto the OCTAVIUS phantom. The plans span a variety of tumor site locations from low to high plan complexity. A patient specific quality assurance (QA) plan was created and delivered for each of the 8 patients using the OCTAVIUS phantom in which the Seven29 detector array was placed. Each plan was delivered four times by rotating the phantom in 45° increments along its longitudinal axis. The treatment plans were delivered using a Novalis Tx with the HD120 MLC. Each of the four corresponding planar doses was exported as a text file for further analysis. An in-house MATLAB code was used to process the planar dose information. A cylindrical geometry-based, linear interpolation method was utilized to generate the measured 3D dose reconstruction. The TPS calculated volumetric dose was exported and compared against the measured reconstructed volumetric dose. Dose difference, dose area histograms (DAH), isodose lines, profiles, 2D and 3D gamma were used for evaluation.
Introduction
The increased use of advanced techniques like intensity modulated radiotherapy (IMRT) for treatment of cancer patients creates higher demands on the quality assurance (QA) program for verification of patient specific delivered dose (1). A key element for successful clinical implementation of IMRT is establishing a dosimetric verification process that can ensure the delivered doses are consistent with calculated doses for each patient (2, 3). There are several methods to establish a dosimetric verification of IMRT plans in the clinic, three of the most common approaches are Technology in Cancer Research & Treatment, Volume 11, Number 1, February 2012 described in the following: In the first method, absolute point dose measurements are acquired in a phantom using dosimeters such as ion chambers. For the second, relative two-dimensional (2D) dose distribution measurement are acquired with dosimeters such as radiographic or radiochromic films or three-dimensional (3D) measurements with polymer gels. The third method of measurement is the verification of a fluence-based pattern perpendicular to the incident beam using devices such as charge coupled device-(CCD) based imaging systems (3) or electronic portal imaging devices (EPIDs) (4). Because inverse planning leads to conformal dose distributions with steep dose gradients at the edges of the target volume and adjacent normal tissues, delivery errors can have adverse effects on the outcome of treatment and tumor control (5) . If the dosimetric accuracy with which these highly tailored distributions are delivered cannot be determined, then the dosimetric benefits seen in the IMRT plan become clinically uncertain (6).
Point detectors, e.g., a single ionization chamber, in a phantom can be used for validating the dose delivered at a single finite point. This verification technique is fast and simple and can be performed for an absolute dose verification of both the total plan and a beam-by-beam verification (7) . An extension of the single point dose measurement is a 2D plane measurement. Films, energy fluence detectors, or electronic portal imaging devices (EPIDs) are suitable for measuring a 2D dose distribution in front of, inside, or behind the phantom (8-13). One drawback of film dosimetry is that it is limited to twodimensional (2D) dose information (14) . With simultaneous film measurements, it is possible to measure in multiple planes of the phantom and to reconstruct a semi-3D dose distribution. This procedure is cumbersome for routine pretreatment verification due to the high workload of developing, digitizing, and comparing the films with the planned dose (7).
The convenience and the reasonable spatial resolution offered by the modern electronic portal imaging devices (EPIDs) has stimulated considerable recent research regarding their use as two-dimensional and three-dimensional dosimeters in IMRT verification procedures (15) (16) (17) (18) . There are several manners in which to use EPIDs for pretreatment verification. The forward approach (7, 13, 16, 17, 19) predicts the dose or the measured grayscale value of the portal imager based on the planned beams. For these, plane differences are quantified against the plan dose (7). A backward approach (20, 21) is used to relate the measured portal dose to the dose at a point, plane, or 3D volume inside the patient (7). Certain downsides to EPID dosimetry are: 1) The EPID is integrated into the linear accelerator and does not provide an independent verification, and 2) The EPID stability and quality assurance must be stringently monitored.
A major limitation of these methods is that it is not evident how errors quantified in a 2D dose at a single depth in a phantom relate to the cumulative errors in a threedimensional (3D) dose distribution within the patient from all the beams in a given IMRT plan (20) . Dose reconstruction with EPIDs have perhaps the greatest potential for meaningful volumetric IMRT QA as it would allow for measured fluence maps to be used for dose reconstruction in the patient CT data set, however the daily use of the EPID system for dose verification diminish the quality and sensitivity of the EPID detectors which may induce a great cost for the maintenance of the equipment. Similarly, full 3D dose Gels (22) have the possibility to measure a 3D dose distribution inside a phantom, but its applicability is subject to a stock of information that can be obtain with an expensive system that is not common in today clinics (7) . With today's technology, efforts have been made to develop systems which can provide volumetric information using dual detector arrays (23) (24) (25) . The purpose of this study was to evaluate the feasibility of developing a method of reconstructing a 3D dose matrix out of multiple planar doses delivered to the OCTAVIUS\Seven29 detector array phantom (PTW, Freiburg, Germany) and compare them against the calculated 3D dose matrix.
Materials and Methods

Patients
The patient cohort consists of 8 RapidArc (Eclipse TPS Ver. 8.6, Varian Medical) plans of various tumor sites previously planned using the Eclipse treatment planning system (2 prostate, 3 brain, 1 spine, 1 H&N, and 1 abdomen). A pretreatment verification plan was calculated for each of the eight patients using the OCTAVIUS\Seven29 phantom detector. The selection of different tumor sites provides different levels of complexity given the degrees of modulation present during the optimization process (Table I) . High dose gradient areas due to the increased modulation make the dose reconstruction process more complex. Most of the patient plans utilized one or two arcs spanning entire 360° degree rotation. The number of MUs delivered ranged from 438 to 1000 MU.
Detector Array and Phantom
The PTW Seven29 -see Figure 1 -detector matrix is composed of 27 3 27 (729) vented ionization chambers. The vented plane-parallel ion chambers are 5 mm 3 5 mm 3 5 mm in size, and the center-to-center spacing is 10 mm. The effective point of measurement is positioned below a 0.5 cm PMMA build-up layer; the lower electrode layer lies on top of a 2 mm thick electrode plate, which is mounted on a 10 mm PMMA base plate. The 5 and 10 mm PMMA layers have a water equivalent thickness of 0.59 and 1.18 cm, respectively (26). The Seven29 and its interface are calibrated by the manufacturer using a certified 60 Co radiation source (27). The sampling acquisition time can be varied from 400 to 999 ms with a supplied polarization voltage of 400 V. As specified by the manufacturer, the Seven29 array performs dose measurements with high reproducibility in the range of 20 to 1000 cGy and dose rate measurements in between 50 to 800 cGy/min with a maximum resolution of 1 mGy/min in a continuous mode. The dimensions of the detector array are 42 3 30 3 2.2 cm 3 with a sensitive area of 27 3 27 cm 2 . When the detector array is placed facing the gantry head, perpendicular to the incoming beam, the data acquisition is done from top to bottom and left to right with reference to the detector array.
The ionization chamber matrix (seven29) is placed in the octagon shaped acrylic phantom: OCTAVIUS -see Figure 1 . The unique shape of the phantom enables rotation around its longitudinal axis in 45° increments. The phantom is made of polystyrene with a physical density of 1.04 g/cm 3 . The phantom is 32 cm lengthwise and 32 cm wide, the cavity in the center of the phantom (30 3 30 3 2.2 cm 3 ) allows for the insertion of the detector matrix. The phantom has a built-in semi cylindrical symmetric compensation cavity to correct for anisotropic behavior of the 2D ion chamber measurements.
Delivery
A pre-treatment verification plan was created for each of the patients in Eclipse. As a first step, each of the patient plans was superimposed onto the OCTAVIUS phantom CT image set. The volumetric dose grid resolution was set to 0.4 cm in all dimensions, and the volumetric dose was then computed. Volumetric doses for each of the pre-treatment verification plans were exported for comparison purposes. Matrix dimensions used were 82 3 82 3 64 data points for all patients. Individual planar doses matching the four expected delivery positions were also exported from Eclipse with matrix dimensions corresponding to 82 3 82 data points. All plans were delivered using a Varian Novalis Tx (Palo Alto, CA) with the HD120 MLC. The same plan was delivered four times using a 45° rotation between deliveries -see Figure 2 . Prior to initial measurements, the Seven29 detector array was corrected for daily output variations by delivering 100 cGy to the ionization chambers array and a K user user factor obtained. This K user factor was retaken each day measurements were obtained. The variability of the K user during the whole delivery period time of 2 weeks was ,0.5%. Text files corresponding to each of the four planar doses delivered for each patient plan were exported and an in-house MATLAB V7.8.0 (MathWorks, Massachusetts, USA) code was used to read and process the planar dose information.
Interpolation and Analysis
Initially, all the delivered planar doses were compared against the corresponding planar doses exported from the TPS. Each of the measurements produced a delivered dose matrix with dimensions of 27 3 27 data points. Once all the delivered planar doses were evaluated, an interpolation of the delivered planar doses was performed to create the interpolated delivered volumetric dose. The octagon shape of the phantom influenced the selection of the interpolation method.
The possible interpolation methods are commonly based on the geometry: square, triangle, rectangle or cylinder. Hence the selection of the linear interpolation over a cylindrical geometry method was based on the almost cylindrical shape of the OCTAVIUS phantom.
During the interpolation, parameters used were restricted due to phantom dimensions and number of detectors in the Seven29 array. The maximum radius utilized was half the distance of the Seven29 detector matrix (14 cm). The interpolation was performed along 360° degrees using an inplane resolution similar to the treatment planning resolution of 0.4 cm in both directions (x and y). The slice thickness resolution was also acquired from the TPS and equated to 0.4 cm (z direction). Each of the interpolated volumetric doses had dimensions similar to the plan volumetric doses of 82 3 82 3 64 data points. A linear interpolation algorithm is the simplest method that can be used over a set of data points in a linear combination, in which the parameters set the influence of each fix point as follows:
The simplest case is the interpolation between two points:
The cylindrical geometry uses the cylinder equation:
The conversion of Cartesian coordinates to cylindrical coordinates is given by the following equations:
x
The radius was defined as the radius of the sample data. Doing so, the signal of the detectors that lie outside the region of interest volume was lost thereby forcing the value of the detector to be nullified.
Fundamental Assumptions for the Interpolation
An important point to take into account when using an interpolation method to create volumetric doses from multiple two-dimensional planes is the fact that the interpolation creates dosimetric errors not present in the treatment plan. During this study a cylindrical-geometry based linear interpolation was used to create a volumetric dose from multiple two-dimensional planes obtained with the OCTAVIUS phantom. This cylindrical-geometry based linear interpolation makes use of points that lay in a cylindrical pattern to create interpolated points in a dose matrix. Due to this, the pixel resolution plays an important role during the interpolation process. The smaller the pixel resolution, the better the interpolation result. For example in Figure 3 the value for pixel number four would be done by averaging the values of pixel 5 and pixel 7 instead of averaging the values of pixel 5 and the pixel that is to the right of pixel 4. This process would 
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lead to an erroneous value for pixel 4 due to the interpolation that is not present in the TPS volumetric dose. In order to quantify the dosimetric errors produced during the interpolation a comparison between the individual delivered planar doses per patient to the corresponding planar doses from the TPS was done. If no differences were seen during this comparison it was safe to assume that the delivered planar doses could be interpolated to create a volumetric delivered dose. Secondly, the calculated planar doses were used to create a Calculated Reconstructed Volumetric Dose (CRVD), which served as a baseline to account for the validity of the interpolation method used when compared against the volumetric dose from the TPS. Finally, it is important to note that because the accuracy of the interpolation improves as one gets closer to the center of the phantom (more measured points per cc), the validity of the method depends on both the location of the spatial dose gradients as well as the magnitude. In the majority of the patients, the dose errors produced by the interpolation method are expected to be outside the high dose region in which case no significant contribution to the pretreatment verification plan outcome is expected.
Results
Delivered Planar Doses
For initial validation, the delivered planar doses were compared against the exported TPS planar doses for each phantom rotation per patient-see Figure 4 . An apparent issue shown in Figure 5 was that the coarse resolution of the Seven29 detector array (1 cm) when compared to the spatial resolution of the TPS planar dose. After equating the spatial dose resolution by down-sampling the TPS planar dose, dose difference images, including maximum and mean doses, were generated for all phantom rotations per plan (Table II) . A dose difference comparison between the OCTAVIUS and TPS planar doses showed no significant percent difference in both high and low dose regions for all patients. The agreement between the measured planes and TPS planes suggests minimal dose discrepancies during the delivery process with the OCTAVIUS/Seven29 detector array. Due to the small dosimetric differences between the measured planar doses and the TPS planar doses, no gamma analysis was done per patient.
Calculated Reconstructed Volumetric Dose (CRVD) vs. Volumetric Plan Dose (VPD)
In order to account for any dose errors introduced by the interpolation algorithm, a Calculated Reconstructed Volumetric Table III shows the maximum dose and the average percent dose difference between the CRVD and VPD for each patient. The Table shows that the maximum dose and average percent dose differences were ,3.0% for all patients. Figure 5 shows the percent dose difference, horizontal profile, dose area histogram and isodose lines for the coronal central axis plane for a selected patient. Figure 6 and Figure 7 show the same analysis for the sagittal and transverse axis plane, respectively. Figures 4-6 provide an insight to the capabilities and limitations of the cylindrical geometry-based, linear interpolation method in reconstructing the volumetric dose. The coronal and sagittal planes analysis shows that the interpolation method is able to reproduce the majority of the high dose region with percent differences ,2.0%, however small regions, with high dose gradients, are noted to possess dose discrepancies up to about 50%. The transverse plane analysis shows that the interpolation method tends to smooth doses outside the high dose region giving significant percent dose differences in small regions. Steep gradients in the high dose regions are larger than the percent difference/DTA tolerances used in the gamma analysis. These discrepancies would lead to a failing gamma analysis that is not a reflection of the delivered method or the treatment plan dose but due to the reconstruction algorithm. Such dose discrepancies should be taken into account when dose analysis is performed. Independent high dose and low dose region analysis can be performed per patient to determine if the discrepancies in the low dose region need to be considered. The majority of the time, the dose in the low dose region is negligible compared to the high dose region that these discrepancies do not play an important factor in the quality assurance analysis.
Measured Reconstructed Volumetric Dose (MRVD) vs. Volumetric Plan Dose (VPD)
Once the interpolation method was benchmarked against the treatment planning system volumetric dose, the Measured Reconstructed Volumetric Dose (MRVD) was created for each of the patients. The maximum dose and the average percent dose difference between the VPD and MRVD for all patients were recorded and the results presented in Table IV . Table IV shows no significant dose differences for the maximum doses and the average percent dose difference were on the order of 3.0%. As expected, good dose agreement is seen in the high dose area with discrepancies noted for some patients in the low dose region. With regards to plan complexity, it appears treatment plans with lower modulation and more homogeneous dose distributionsi.e., prostate -produced better agreement between the calculated and interpolated dose matrices. Conversely, plans with higher modulation produced larger discrepancies. Figure 8 , Figure 9 , and Figure 10 show dose differences, horizontal profiles, dose area histograms and isodose lines for selected prostate patient. The percent dose difference, DAH and profile show good agreement between the interpolated volumetric dose and the planned volumetric dose in the high dose region ,2.0%. The isodose lines for the transversal plane show that the interpolation smoothes the dose outside the high dose region which produced differences within the plan and the reconstructed dose. Similar results were obtained for the other patients. Table V shows the 3D gamma index for all the patients using four different sets of criteria for the dose difference and the DTA. It can be seen that for the less restrictive criteria (5%, 5 mm) the average passing rate is 92.4%. When more restrictive criterion (2%, 2 mm) was used, the average passing rate drops to a value of 80.1%.
Validation of the gamma analysis
The validation of the gamma analysis calculation was accomplished by benchmarking the gamma index obtained with the MATLAB code against the gamma index obtained from the PTW and RIT software. In all three cases, the gamma analysis was performed using the methodology outline by Low et al. (28) . The coronal central axis plane for the reconstructed and plan dose volumes were exported to the PTW and RIT software were gamma analysis was performed. The gamma index was obtained by suppressing pixels with 10% of the maxim plan dose and 3%/3 mm gamma tolerances. Table VI shows the results. It can be seen that the gamma index done with the MATLAB code agrees with the gamma index of the PTW software with percent dose differences ,2.0%. The MATLAB gamma index and the RIT gamma index differ with percent differences ~10% with the RIT software giving the higher gamma indexes. 
Discussion
The purpose of this project was to develop a fast and accurate way to reconstruct a 3D dose matrix from several 2D dose planes obtained with the Seven29 detector array and the OCTAVIUS phantom. The use of a single ion chamber for point dose measurement and film for a 2D map provide information solely of a single plane out of the entire dose volume. In the past, this information may have been adequate to validate the TPS dose. However, the implementation of newer technology (e.g., RapidArc) increases the complexity of radiation delivery and further mandates an independent method of pre-treatment verification. The practice is evolving from single ion chamber measurements (point dose) and film (2D) to detector arrays and EPIDs (2D). However, the quantification continues to be planar.
The strategy selected in this project makes use of current, commercially available technology (detector arrays) and attempts to further improve its utility by reconstructing a semi-measured 3D dose distribution which can be compared to the 3D TPS dose distribution. This semi-measured 3D dose is able to provide information regarding the overall volumetric dose and provides a more accurate validation of the dose distribution. The 3D dose gamma index also provides an overall view of the effectiveness of the plan outcome in This project is based on measurements using the Seven29 detector array within the OCTAVIUS phantom. The calibration of the seven29 array is an important component of this project because that is what defines the accuracy of the dose plane delivery. During the calibration of the detector array, small differences ,0.5% were found when a new calibration factor K user was taken as every measurement day. As a first step, each individual planar dose was compared against its corresponding dose plane from the TPS with percent differences ,1% for all patients and all planes.
The CRVD and the VPD dose comparison showed that the interpolation method does introduces sampling dose errors in small regions in the high dose gradients. These errors are usually outside of the high dose area. However, an individual high dose, low dose region analysis should be performed per patient when the interpolation algorithm is used to verify that these small regions of dose discrepancies. The user should be able to differentiate between a dose error produce by the delivery or TPS and the one introduce by the interpolation algorithm. When dose analysis per individual plane was done for each of the patients no significant dose differences were observed for all of the patients, however the interpolation algorithm introduced small regions of dose discrepancies not present in these individual planes. When a pre-treatment verification plan is done using this technique if the individual plane analysis agrees but the volume comparison fails the user needs to indentify the level of disagreement taking into account the imbedded dose differences introduced by the interpolation method in small regions of the high dose gradients. If the volumetric comparison fails in these regions it can be safe to assume that the error is not present in the TPS plan.
The number of planes used during the interpolation method corresponded to the maximum number of possible rotations the user can realize with the OCTAVIUS phantom. However, the interpolation was also done by the use of three and two planes in order to optimize the number of necessary planes to obtain the best possible interpolated volumetric dose. A 3D gamma analysis (3%, 3 mm) per number of planes used during the interpolation is presented in Figure 11 . In the Figure, the gamma indexes per patient were normalized to the corresponding gamma index obtained when four planes were used. The Figure shows percent differences ,5% for all planes and all patients. In Figure 11 it is clear that the cylindrical-geometry based linear interpolation method used in this study is not able to differentiate between the volumetric doses produced as a function of No. of planes used. The reason could be the dosimetric differences are smaller than gamma tolerances used (3%, 3 mm) for the comparison. As the number of planes used during the interpolation increases the interpolation accuracy should improves as well, however the physical limitations of the phantom allows only four rotations during the delivery process.
The advantage of having volumetric dose information over a single 2D plane lies in the fact that the user can identify errors in the volumetric plan dose away from the typical central axis plane. The effectiveness of the technique can be seen when small dose volumes are treated with high doses such as VMAT SBRTs or when the plan complexity requires higher level of certainty that the entire PTV would be target while the OARs are spared.
The overall result of the study is a fast and easy way to reconstruct a 3D dose that can provide a more complete set of information than a single point dose measurement and a single plane of dose. Moreover, this was done using the current technology without the necessity of new hardware adjustments or complex calculations. The Seven29 detector array and the OCTAVIUS phantom provide the technology necessary to implement this method in the clinic.
Conclusions
A simple cylindrical interpolation method is able to predict good agreement in the high dose region between the reconstructed volumetric dose and the planned volumetric dose. The interpolation algorithm introduces dose discrepancies in small regions of the high dose gradients that should be keep in mind when using this technique. This technique is a good starting point to establish a benchmark for the level of manipulation necessary to obtain 3D dose delivery quality assurance using current technology.
